P
23.67
-0.08 (-0.34%)
| Previous Close | 23.75 |
| Open | 23.59 |
| Volume | 279,825 |
| Avg. Volume (3M) | 729,082 |
| Market Cap | 2,852,542,720 |
| Price / Earnings (TTM) | 215.18 |
| Price / Earnings (Forward) | 43.67 |
| Price / Sales | 1.66 |
| Price / Book | 4.35 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2025 - 12 May 2025 |
| Profit Margin | 0.83% |
| Operating Margin (TTM) | 1.14% |
| Diluted EPS (TTM) | 0.110 |
| Quarterly Revenue Growth (YOY) | 4.60% |
| Quarterly Earnings Growth (YOY) | 55.00% |
| Total Debt/Equity (MRQ) | 0.82% |
| Current Ratio (MRQ) | 1.86 |
| Operating Cash Flow (TTM) | 109.28 M |
| Levered Free Cash Flow (TTM) | 104.86 M |
| Return on Assets (TTM) | 0.99% |
| Return on Equity (TTM) | 2.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | Privia Health Group, Inc. | Bullish | Bullish |
AIStockmoo Score
1.1
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | -1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.13 |
|
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 10.60% |
| % Held by Institutions | 102.35% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rubicon Founders Llc | 31 Dec 2024 | 5,773,522 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 40.00 (Piper Sandler, 68.99%) | Buy |
| Median | 29.50 (24.63%) | |
| Low | 26.00 (JMP Securities, 9.84%) | Buy |
| 26.00 (Stephens & Co., 9.84%) | Buy | |
| Average | 30.17 (27.46%) | |
| Total | 6 Buy | |
| Avg. Price @ Call | 23.97 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Needham | 21 Mar 2025 | 30.00 (26.74%) | Buy | 23.34 |
| 28 Feb 2025 | 30.00 (26.74%) | Buy | 24.97 | |
| Canaccord Genuity | 28 Feb 2025 | 30.00 (26.74%) | Buy | 24.97 |
| Citizens Capital Markets | 28 Feb 2025 | 29.00 (22.52%) | Buy | 24.97 |
| Piper Sandler | 28 Feb 2025 | 40.00 (68.99%) | Buy | 24.97 |
| JMP Securities | 14 Feb 2025 | 26.00 (9.84%) | Buy | 25.24 |
| Stephens & Co. | 07 Jan 2025 | 26.00 (9.84%) | Buy | 20.30 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 27 Feb 2025 | Announcement | Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results |
| 24 Jan 2025 | Announcement | Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |